- Home
- RUN vs HUMAW Comparison
RUN vs HUMAW Comparison
Compare RUN & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RUN
- HUMAW
- Stock Information
- Founded
- RUN 2007
- HUMAW 2004
- Country
- RUN United States
- HUMAW United States
- Employees
- RUN N/A
- HUMAW 220
- Industry
- RUN Industrial Machinery/Components
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- RUN Miscellaneous
- HUMAW Health Care
- Exchange
- RUN Nasdaq
- HUMAW Nasdaq
- Market Cap
- RUN 2.8B
- HUMAW N/A
- IPO Year
- RUN 2015
- HUMAW N/A
- Fundamental
- Price
- RUN $7.49
- HUMAW $0.54
- Analyst Decision
- RUN Buy
- HUMAW
- Analyst Count
- RUN 20
- HUMAW 0
- Target Price
- RUN $15.17
- HUMAW N/A
- AVG Volume (30 Days)
- RUN 24.8M
- HUMAW 14.2K
- Earning Date
- RUN 05-07-2025
- HUMAW 03-21-2025
- Dividend Yield
- RUN N/A
- HUMAW N/A
- EPS Growth
- RUN N/A
- HUMAW N/A
- EPS
- RUN N/A
- HUMAW N/A
- Revenue
- RUN $2,083,802,000.00
- HUMAW N/A
- Revenue This Year
- RUN $10.81
- HUMAW N/A
- Revenue Next Year
- RUN $12.53
- HUMAW N/A
- P/E Ratio
- RUN N/A
- HUMAW N/A
- Revenue Growth
- RUN N/A
- HUMAW N/A
- 52 Week Low
- RUN $5.45
- HUMAW $1.18
- 52 Week High
- RUN $22.26
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- RUN 44.39
- HUMAW N/A
- Support Level
- RUN $6.48
- HUMAW N/A
- Resistance Level
- RUN $7.48
- HUMAW N/A
- Average True Range (ATR)
- RUN 0.89
- HUMAW 0.00
- MACD
- RUN -0.53
- HUMAW 0.00
- Stochastic Oscillator
- RUN 18.81
- HUMAW 0.00
About RUN Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed either by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.